Health Monitor Liechtenstein

AGP Executive Report

Last update: 2 hours ago

Weight-loss drug deal: Gan & Lee Pharmaceuticals’ shares jumped after it sold European rights to its biweekly GLP-1 injection Bofenglutide to Menarini for up to about USD839m, with Menarini covering overweight/obesity across EU states plus the UK, Switzerland, Norway, Iceland, Liechtenstein and parts of the Balkans. Local health policy: Liechtenstein’s regent, Prince Alois, says he will block any move to legalise abortion, citing his veto power as support grows for first-trimester access. Healthcare data breach: Brown Health Medical Group-MA is warning 311,000 people after a December 2025 file-server breach exposed personal, medical/disability, and financial details. Travel health & admin: A singer’s urgent passport plea highlights a common rule for travel to EU countries and Switzerland/Norway/Iceland/Liechtenstein: passports must have at least three months left and be issued within the last 10 years. Wellness-adjacent business: Dropvital, based in Schaan, Liechtenstein, positions its water-treatment and organic medicinal mushroom approach around traceability and quality.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

Jul. 28, 2026

Perspectify News

Learn about labels.

Labels

Labels On

Filter

Aug. 7, 2026

Liechtenstein prince vows to block any move to legalise abortion

The Catholic Herald

2 hours ago

China’s Gan & Lee Soars After Selling Rights to Weight Loss Drug in Europe to Menarini for USD839 Million

YiCai Global |

Owner: Chinese Government info about owner

YiCai Global

Indeterminate

Owned By	Chinese Government through Shanghai Municipal Government
Year Founded	2016
Website	www.yicaiglobal.com
Domain Registration Year	2016
Access Type	open
Publication Location	China, Shanghai
Owner Country	China

We welcome your feedback!
If you have comments or corrections, let us know.

Aug. 5, 2026

311,000 Impacted by Brown Health Medical Group-MA Data Breach

SecurityWeek |

Owner: Mike Lennon info about owner

SecurityWeek

Indeterminate

Owned By	Mike Lennon through Wired Business Media, Inc.
Year Founded	2009
Website	www.securityweek.com
Domain Registration Year	2002
Access Type	open
Publication Location	United States, Massachusetts, Boston
Owner Country	United States

We welcome your feedback!
If you have comments or corrections, let us know.

Aug. 3, 2026

Liechtenstein’s archaic abortion laws need to be modernised. But a prince is standing in the way

The Guardian |

Owner: The Scott Trust info about owner

The Guardian

Center-left

Owned By	The Scott Trust through Guardian Media Group
Year Founded	1959
Website	theguardian.com
Domain Registration Year	1994
Access Type	hybrid
Publication Location	United Kingdom, London
Owner Country	United Kingdom

We welcome your feedback!
If you have comments or corrections, let us know.

Jul. 31, 2026

Pharmanovia licenses China-approved PARP drug for up to €423.5M

European Biotechnology |

Owner: Michael Kuhrt & Joachim Eeckhout info about owner

European Biotechnology

Neutral

Owned By	Michael Kuhrt & Joachim Eeckhout through BIOCOM AG
Year Founded	1986
Website	european-biotechnology.com
Domain Registration Year	2007
Access Type	hybrid
Publication Location	Germany, Berlin
Owner Country	Germany

We welcome your feedback!
If you have comments or corrections, let us know.

Aug. 5, 2026

IMPACT Partners Pharmanovia to Expand Senaparib Across 66 Countries

Pharma Journalist |

Owner: Kellen Media info about owner

Pharma Journalist

Neutral

Owned By	Kellen Media (Non-transparent)
Year Founded	2017
Website	https://www.pharmajournalist.com/
Domain Registration Year	2017
Access Type	open
Publication Location	India, New Delhi
Owner Country	India

We welcome your feedback!
If you have comments or corrections, let us know.

Aug. 3, 2026

IMPACT Therapeutics grants Pharmanovia exclusive $488m rights to senaparib

Pharmaceutical Business Review |

Owner: Michael "Mike" Danson info about owner

Pharmaceutical Business Review

Indeterminate

Owned By	Michael "Mike" Danson through Progressive Trade Media Ltd.
Year Founded	2003
Website	www.pharmaceutical-business-review.com
Domain Registration Year	2003
Access Type	open
Publication Location	United Kingdom, London
Owner Country	United States

We welcome your feedback!
If you have comments or corrections, let us know.

Aug. 2, 2026

Associate Product Manager - UK Health Security Agency

Civil Service World |

Owner: Political Holdings Ltd info about owner

Civil Service World

Neutral

Owned By	Political Holdings Ltd (Elizabeth Entwistle Director)
Year Founded	2004
Website	https://www.civilserviceworld.com/
Domain Registration Year	2009
Access Type	open
Publication Location	United Kingdom, London
Owner Country	United Kingdom

We welcome your feedback!
If you have comments or corrections, let us know.

As featured in:

@ Journalists!

Join

Helena Bachmann

MUCKRACK.COM

Vlado Apostolov

BALKANINSIGHT.COM

Press releases

Publish your press release

Jul. 23, 2026

Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing

GlobeNewswire, Inc.

Jul. 24, 2026

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

GlobeNewswire, Inc.

Aug. 10, 2026

American Fusion Inc. (OTC: AMFN) Appoints John Gerdin to Board of Directors as Independent Director and Strategic Advisor

GlobeNewswire, Inc.

Jul. 1, 2026

Serbia's Vučić Sends Signal to Brussels and Moscow by Hosting Zelenskyy With Pomp and Circumstance

Discover Affinity Group Publishing

Russia and Ukraine Exchange Deadly Overnight Strikes

EU's New Border Entry System Causing Long Lines at Airports